Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rifabutin vs Rifabutin/Ethambutol for MAC Prophylaxis in AIDS
NCT00002343Phase 4Completed
- Sponsor
- Pharmacia
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rifabutin in Mycobacterium avium complex infection (MAC) (2 arms), sponsored by Pharmacia. Primary endpoints: Serum rifabutin levels at 12 months and Incidence of Mycobacterium Avium Complex (MAC) Bacteremia at 12 months. Status: completed.
02
Drugs
rifabutin
03
Conditions
Mycobacterium avium complex infection (MAC)
Beyond the preview
Go deeper on NCT00002343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002343.